Calf Plasma Research Articles

Immediate prepartum supplementation accelerates progesterone decline, boosting passive immunity transfer in tropically adapted beef cattle

Context Poor nutrition of late-pregnant cows is highly prevalent in the dry tropics and associated with high levels of calf mortality. Aims It was hypothesised that supplementation with protein to prepartum cows would restore the normal decline in progesterone prepartum and increase the transfer of passive immunity to calves, with this being further enhanced by inclusion of yeast fermentation products. Methods In total, 84 heifers and 45 cows were selected for a completely randomised block design, with the following three dietary treatments: unsupplemented, receiving ad libitum low-protein hay only; hay supplemented with 1 kg/day of protein; and supplementation with both protein and 14 g/day of a Saccharomyces cerevisiae fermentation product. Supplementation occurred for an average of 14 days before calving. Cow plasma samples in the week before parturition, and the first plasma sample after parturition, were analysed for progesterone and metabolites. Newborn calves were weighed and blood-sampled three times per week during the first 2 weeks after birth. The first two calf plasma samples were analysed for total protein, albumin, and globulin concentrations. Data were analysed using a mixed-effects model and the decline of progesterone concentration over time was modelled using a non-linear segmented model. Key results Prepartum supplementation reduced cow liveweight loss, increased glucose, reduced fat mobilisation metabolites and tended to increase average daily weight gain of calves. Including yeast fermentation products in the supplement tended to increase the transfer of passive immunity to calves. Supplementation decreased plasma progesterone before parturition and including yeast fermentation products further advanced the initiation of progesterone decline. Conclusion Protein supplementation of protein-deficient beef cows during late pregnancy helps restore the normal decrease in progesterone before parturition. Implications This study identified a plausible hormonal mechanism explaining how poor nutrition around birth can increase calf loss, opening new possibilities for short-term diet management strategies to reduce calf mortality and improve calf health.

PSXV-27 Late-Breaking: Evaluation of antioxidant capacity in receiving beef calves challenged with lipopolysaccharide (LPS)

Abstract The objective of this study was to evaluate antioxidant capacity in plasma of beef calves challenged with LPS. Following an initial feeding period of 40 d, steers (n = 32; 379 kg ± 30.7) were transported to the Livestock Issues Research Unit’s Bovine Immunology Research and Development Complex and challenged intravenously with LPS (0.25 µg/kg BW) on d 41. Blood samples were collected via jugular catheter at -2, 0, 2, 4, 6, 8, 10, 12, 18, 24, 36 and 48 h relative to the LPS challenge at 0 h. Blood samples were processed to isolate plasma for indicators of oxidative stress with a colorimetric assay to determine ferric reducing antioxidant power (FRAP) values via concentration of ferrous iron (µM). Data were analyzed as repeated measures using the GLIMMIX procedure of SAS. Antioxidant values did vary with time (P < 0.001) being greater (P < 0.05) at -2, 0, 2, 36, and 48 h. Antioxidant capacity was reduced at 6 and 8 h (P < 0.05), with the least FRAP value observed at 8 h post-challenge. Antioxidant capacity increased (P < 0.05) again at 10 h, showing similar (P > 0.05) concentrations to those observed at 4 h. By 24 h post-challenge, plasma FRAP values increased (P < 0.05) similar to initial values at -2, 0, and 2 h. It can be inferred that oxidative stress contributes to reduced antioxidant capacity, ultimately interfering with animal growth and productivity. While these values reflect the oxidative stress response to an acute endotoxin challenge, and a subsequent recovery returning to homeostasis within 24 to 48 h, they may also correlate with other physiological and immunological indicators associated with an acute endotoxin challenge.

97 Awardee Talk: Feeding Essential Fatty Acids to Late-gestating Beef Cows Optimizes Performance and Health Responses of the Offspring

Abstract Option 1, Fetal Programming Only: Non-lactating, pregnant, multiparous Angus × Hereford cows (n = 104) were ranked by pregnancy sire (1 of 2 sires), body weight (BW), and body condition score (BCS) on d -15 of the experiment (d 180 of gestation). Cows were then assigned to receive: (1) 195 g/cow daily of CSSO (n = 52) or 2) 170 g/cow daily of CON (n = 52). Cows received treatments individually from d 0 to calving. Calves were weaned on d 290 of the experiment, preconditioned for 35 d, and placed in a feedyard until slaughter (d 514). Cows receiving CSSO and their calves had greater (P < 0.01) plasma concentrations ω-6 PUFA compared with CON after calving. Colostrum IgG and calf plasma IgG concentrations 24 h after birth were greater (P ≤ 0.02) in CSSO vs. CON cattle. Calves from CSSO cows had greater (P ≤ 0.05) expression of adipogenic and myogenic genes in the longissimus muscle compared with CON. No treatments differences in birth BW, weaning BW, and final preconditioning BW were noted (P ≥ 0.36). Average daily gain and final BW in the feedyard were greater (P ≤ 0.05) in steers from CSSO cows compared with CON. The incidence of calves diagnosed with BRD that required a second antimicrobial treatment was less (P = 0.03) in calves from CSSO cows, resulting in reduced (P = 0.05) need of treatments to regain health compared with CON. Upon slaughter, LM area was greater (P = 0.03) in calves from CSSO cows compared with CON. Collectively, these results are indicative of programming effects on postnatal offspring growth and health resultant from CSSO supplementation to late-gestating cows. Hence, supplementing CSSO to beef cows during pregnancy might be a feasible alternative to optimize offspring productivity and welfare. Option 2, Fetal Programming and Fat Tubs: Two experiments were conducted to evaluate: (1) effects of calcium salts of soybean oil (CSSO) supplementation to late gestating beef cows on the performance of the offspring; (2) the viability of utilizing low-moisture molasses-based blocks (LMB) as a delivery method for CSSO supplementation. In experiment 1, non-lactating, pregnant, multiparous Angus × Hereford cows were assigned to receive: (1) 195 g/cow daily of CSSO (n = 52) or (2) 170 g/cow daily of CON (n = 52) from d 195 of gestation until calving. CSSO cattle had greater (P < 0.01) plasma concentrations ω-6 PUFA; greater (P ≤ 0.02) colostrum and calf plasma IgG concentrations; greater (P ≤ 0.05) expression of adipogenic and myogenic genes in the longissimus muscle (LM); required fewer microbial treatments for BRD (P = 0.05) and had greater LM area compared to CON cohorts. In experiment 2, non-lactating, non-pregnant, multiparous beef cows were allocated to 1 of 9 pens (n = 9 pens; 4 cows/pen) and each pen was assigned to receive: 1) NOSUPP, hay only diet; 2) LMB, self-fed LMB supplement containing 24.7% DM CSSO; 3) CONC, hand-fed supplement identical to LMB. The design was a replicated 3 x 2 Latin square with 2 periods of 42 d, and a 21-d washout interval. Supplement DM intake did not differ (P = 0.39) between LMB and CONC cows from d 14 to 42 as designed, despite a greater variation in daily intake of LMB vs. CONC (treatment × day interaction; P < 0.01). No treatments effects were noted (P ≥ 0.40) for hay intake, BCS, and BW. From d 14 to 42, plasma concentrations of, ω-6 PUFA (P < 0.01) in CONC and LMB vs. NOSUPP cows. Hence, the use of self-fed LMB appears to be a valid strategy to provide CSSO to forage-fed beef cattle.

ВЛИЯНИЕ ПРЕПАРАТОВ «ИМУНОФАН» И «ФОСПРЕНИЛ» НА МОРФОЛОГИЧЕСКИЙ СОСТАВ КРОВИ ТЕЛЯТ

The aim of the work was to study the effect of immunomodulators "Imunofan" and "Fosprenil" on the intensity of nitric oxide (II) formation and the morphological composition of blood in calves. Increased levels of stable nitric oxide (II) metabolites in the blood plasma of calves after the use of immunomodulators indicates the participation of NO in nonspecific immunity reactions. Also the established relationship between the level of stable nitric oxide (II) metabolites and the number of stab neutrophils proves that NO is one of the regulators of neutrophil activity.

Effects of a Maternal Essential Fatty Acid and Conjugated Linoleic Acid Supplementation during Late Pregnancy and Early Lactation on Hematologic and Immunological Traits and the Oxidative and Anti-Oxidative Status in Blood Plasma of Neonatal Calves.

Simple SummaryFatty acids play an important role in the regulation of inflammation and oxidative stress. The birth and the neonatal period are characterized by a high risk of inflammation and an increased production of reactive oxygen species in the calf. The present study deals with the effects of a different maternal fatty acid supply including the supplementation of saturated fatty acids by coconut oil, essential fatty acids, conjugated linoleic acid or a combination of essential fatty acids and conjugated linoleic acid on the immunological and oxidative as well as anti-oxidative status of neonatal calves. Maternal essential fatty acid as well as conjugated linoleic acid supply affected the inflammatory response and the oxidative and anti-oxidative status of the neonatal offspring. Essential fatty acids might have beneficial effects on the prevention of dysregulated inflammation after birth and reduced the plasma bilirubin concentrations in this period. Conjugated linoleic acid and saturated fatty acids might increase the inflammatory response. Similarly, plasma bilirubin increased, which in part might serve as a protector against oxidative stress in the early phase after birth.Fatty acids are known for their regulatory role in inflammation and oxidative stress. The present study investigated 38 calves born from dams, abomasally supplemented with coconut oil, essential fatty acids (EFA), conjugated linoleic acid (CLA) or EFA + CLA, according to immunological traits and the oxidative and anti-oxidative status for the first 5 days of life. On day 2 of life, plasma total bilirubin, cholesterol, interleukin 1-β and ferric ion reducing anti-oxygen power (FRAP) were lower in calves with than without maternal EFA supplementation, and FRAP additionally on day 4. On day 3, the concentrations of reactive oxygen metabolites were higher in calves with than without maternal EFA supplementation and additionally on day 5 together of retinol. Total leucocyte counts were decreased in the EFA group compared to the CLA group on day 5. Lymphocyte proportions decreased from day 1 to 5 only in the EFA + CLA group. On day 2, plasma total protein was higher in CLA and EFA + CLA than in EFA calves. Similarly, CLA calves had higher interleukin 1-β concentrations compared to EFA + CLA calves. FRAP was decreased by CLA on day 4. Overall, the maternal fatty acid supply affected the inflammatory response and the oxidative and anti-oxidative status of the neonatal offspring.

Growth, physiology, and coccidiosis infestation of suckling beef calves grazing warm-season grasses and offered creep-feeding supplementation with or without monensin.

This study evaluated the growth, physiology, and coccidiosis infestation of suckling beef calves provided monensin and grazing limpograss (Exp. 1) or bahiagrass (Exp. 2) pastures. Treatments were randomly assigned to pastures (4 pastures/treatment; 3 cow-calf pairs/pasture in Exp. 1; 4 pastures/treatment; 10 cow-calf pairs/pair of pastures in Exp. 2) and comprised of supplementation of 0.40kg/d of soybean meal added or not with monensin (20mg/kg of total DM intake) for 112 and 78days before weaning in Exp. 1 and 2, respectively. In Exp. 1, supplement DM disappearance tended (P = 0.10) to be less for calves supplemented with vs. without monensin, but treatment × day and treatment effects were not observed (P ≥ 0.18) for herbage mass (HM), herbage allowance (HA), cow body condition score (BCS), calf average daily gain (ADG), calf plasma data, and fecal coccidia egg count. In Exp. 2, forage nutritive value, HM and HA, and cow BCS did not differ (P ≥ 0.43) between treatments. Supplemental monensin did not impact (P ≥ 0.78) plasma concentrations of insulin-like growth factor 1 but increased (P ≤ 0.05) calf overall ADG and plasma concentrations on day 78 and reduced plasma concentrations of urea nitrogen (PUN) on day 78 and fecal coccidia egg count on day 78 compared to calves provided no monensin supplementation. Hence, monensin supplementation successfully improved growth performance of creep-fed suckling beef calves, when herbage mass was not a limiting factor and coccidiosis infestation occurred.

Salbutamol Residue in Plasma and Urine of Balinese Calves after Single-Dose Administration

Salbutamol, a short-acting β2-adrenergic receptor agonist, due to illegal use in animal feed, is very dangerous for the safety of animal origin products. The purpose of this study is to determine the residue of salbutamol in plasma and urine of balinese calf after a single-dose administration. Three calves were given of feed fortification of salbutamol (10 mg/kg body weight). The salbutamol concentrations were measured in the plasma and urine. Samples were extracted with perchloric acid and purified by cation exchange solid phase extraction (SPE), then analyzed by High-Performance Liquid Chromatography (HPLC) with a photodiode array detector using an RP C18 column with a mixed mobile phase of purified water pH 3.0 (adjusted with phosphoric acid) and acetonitrile (90:10, v/v). The highest salbutamol concentration in the plasma sample was 0.28±0.15 μg/mL at 12 hours and decreased after 24 hours after feeding. The highest concentration of salbutamol in urine was 15.85±4.42 μg/mL at 18 hours and decreased gradually starting at 24 hours. This result concluded that salbutamol residues mostly excreted in the urine, and the highest salbutamol residues in plasma samples formed faster but also decreased more rapidly than residues formed in urine. The residue formed in plasma is lower than that in the urine.

Comparative Effects of Milk Containing A1 versus A2 β-Casein on Health, Growth and β-Casomorphin-7 Level in Plasma of Neonatal Dairy Calves.

Simple SummaryBovine milk generally contains two types of the milk protein β-casein, A1 and A2. Enzymatic digestion of the A1 type yields the opioid peptide β-casomorphin-7, which is suggested to adversely affect human and animal health. This study aimed to compare the effects of milk containing either homozygote A1 or A2 β-casein on health and growth parameters in 47 dairy calves during the first three weeks of life. Additionally, we studied, for the first time, the levels of intact β-casomorphin-7 in plasma of calves fed milk of alternative β-casein genotypes. Milk feeding of “A2-milk” led to a lower milk intake and a looser fecal consistency (higher prevalence of diarrhea) compared to “A1-milk”. Nevertheless, weight gains and end weights of calves of both feeding groups were similar, which might be caused by the associated higher protein content of milk containing the A2 variant. Intact β-casomorphin-7 was detected in plasma after A1- and A2-milk consumption, but was almost 5 times higher for A1-calves. In summary, A2-milk minimized the cleavage of the opioid peptide β-casomorphin-7 and might have advantages in the development of pre-weaned dairy calves.Research has shown that digestion of A1 β-casein (β-CN) affects gastrointestinal motility and opioid activity through the release of the peptide β-casomorphin-7 (β-CM7). In the case of the A2 variant, the cleavage of β-CM7 does not occur or occurs at a very low rate. Therefore, the aim of the study was to compare the effects of milk containing either homozygote A1 or A2 β-CN on health and growth parameters of dairy calves. Forty-seven neonatal calves (24 females, 23 males) of the breeds German Holstein (GH, n = 9), German Simmental (GS, n = 33) and their crossing (GH × GS, n = 5) were used in a 21-day feeding study. Fecal score (FS), respiratory frequency (RF), and rectal body temperature (BT) were recorded daily, whereas body weight was measured at birth and at day 21 to estimate the average daily weight gain (ADG). Additionally, blood was collected from calves three times during the experimental period and, for the first time, the respective plasma samples were analyzed for intact β-CM7. Consumption of A2-milk led to a lower daily milk intake (dMI) (p < 0.05). Furthermore, fecal consistency was softer for calves fed A2-milk (p < 0.05). Although 44% of A2-calves had diarrhea or revealed a tendency towards it (FS ≥ 3), A1-calves had a prevalence of 21%. Calves with a FS of 4 were offered an electrolyte solution and received a dietary food supplement for the stabilization of the fluid and electrolyte balance. Nevertheless, similar ADG and end weights (EW) of calves fed A1- or A2-milk (p > 0.05) indicate that A2-milk may compensate higher diarrhea rates and lower dMI due to the associated higher protein content. This is the first report of intact β-CM7 in plasma of calves fed milk of either A1 or A2 β-CN. Evidence from this study suggests that due to the change in the amino-acid sequence, A2-milk might be able to prevent or, at least, to minimize the cleavage of β-CM7 in calves.

Influences of Maternal Conjugated Linoleic Acid and Essential Fatty Acid Supply During Late Pregnancy and Early Lactation on T and B Cell Subsets in Mesenteric Lymph Nodes and the Small Intestine of Neonatal Calves.

Conjugated linoleic acid (CLA) isomers are known for their health-promoting effects in mammals and metabolic functions in dairy cows and are synthesized in the forestomach depending on essential fatty acid (EFA) intake. The current preliminary study investigated effects of a maternal fatty acid supplementation (MFAS) during late pregnancy and early lactation with coconut oil (CON, control), CLA (Lutalin®), or CLA + EFA (Lutalin® linseed oil; safflower oil) on plasma fatty acid composition and T and B cell subsets in mesenteric lymph nodes (MLN) and the small intestine of 5-day-old calves. MFAS of CLA + EFA increased α-linolenic, eicosapentaenoic, docosapentaenoic, and n-3 fatty acid proportions in calf plasma fat on days 1 and 5 after birth (P < 0.05). On day 5, CLA and CLA + EFA calves showed higher plasma fat trans-10, cis-12 CLA proportions, and CLA calves had higher plasma cis-9, trans-11 CLA proportions compared with CON calves (P < 0.1). MFAS of CLA tended to increase CD4+ T cell subsets in MLN and increased CD21+ B cell subsets in ileal lamina propria compared with CON but decreased CD2+ T cell subsets in jejunal lamina propria (P < 0.05). CLA + EFA decreased CD4+ T cell subsets in MLN compared with CLA (P < 0.05). MFAS of CLA seemed to affect the intestinal adaptive immune system of calves, but additional EFA supplementations reversed CLA effects. Possible direct CLA and EFA effects or whether changes in milk composition affected this immune modulation must be clarified in further studies.

Supplementing Ca salts of soybean oil to late-gestating beef cows: impacts on performance and physiological responses of the offspring.

This experiment compared the performance and physiological responses of the offspring from cows supplemented with Ca salts of soybean oil (CSSO) or prilled saturated fat (CON) during late gestation. Nonlactating, pregnant, multiparous Angus × Hereford cows (n = 104) that conceived during the same fixed-time artificial insemination protocol were assigned to this experiment. Cows were ranked by pregnancy sire (one of two sires), body weight (BW), and body condition score (BCS) on day -15 of the experiment (day 180 of gestation). Cows were then assigned to receive (dry matter basis) 415 g of soybean meal per cow daily in addition to: 1) 195 g/cow daily of CSSO (n = 52) or 2) 170 g/cow daily of CON (n = 52). Cows were maintained in two pastures (26 cows/treatment per pasture) and received daily 12.7 kg/cow (dry matter basis) of grass-alfalfa hay from day -15 to calving. Cows were segregated into 1 of 24 feeding pens three times weekly and received treatments individually from day 0 to calving. Calves were weaned on day 290 of the experiment, preconditioned for 35 d (day 291 to 325), and transferred to a feedyard, where they remained until slaughter (day 514). Cows receiving CSSO and their calves had greater (P < 0.01) plasma concentrations of linoleic acid and total ω-6 PUFA compared with CON after calving. Concentrations of immunoglobulin G in the colostrum and in calf plasma 24 h after birth were greater (P ≤ 0.02) in CSSO vs. CON cattle. Calves from CSSO cows had greater (P ≤ 0.05) expression of adipogenic (adipocyte fatty acid-binding protein and stearoyl-CoA desaturase) and myogenic (myogenic differentiation 1 and myogenin) genes in the longissimus muscle (LM) compared with CON. No treatment differences in birth BW, weaning BW, and final preconditioning BW were noted (P ≥ 0.36). Average daily gain and final BW in the feedyard were greater (P ≤ 0.05) in steers from CSSO cows compared with CON. The incidence of calves diagnosed with BRD that required a second antimicrobial treatment was less (P = 0.03) in calves from CSSO cows, resulting in reduced (P = 0.05) need of treatments to regain health compared with CON. Upon slaughter, LM area was greater (P = 0.03) in calves from CSSO cows compared with CON. Collectively, these results are indicative of programming effects on postnatal offspring growth and health resultant from CSSO supplementation to late-gestating cows. Hence, supplementing CSSO to beef cows during pregnancy might be a feasible alternative to optimize offspring productivity and welfare.

GROWTH PERFORMANCE AND IMMUNITY RESPONSE OF SUCKLING FRIESIAN CALVES FED ON RATION SUPPLEMENTED WITH ORGANIC OR NANO SELENIUM PRODUCED BY LACTIC ACID BACTERIA

Eighteen suckling Friesian calves with average live body weight of 32.70±0.79 kg were divided into three comparable groups based on sex and birth weight. All calves were fed on a whole milk, starter and berseem hay without supplement in the control group or supplemented with 0.3 mg Se/kg DM intake as organic selenium (OSe) or nano selenium (NSe) for 2nd and 3rd groups. The results showed that organic-and nano selenium groups recorded significantly (P 0.05) affected by selenium additives. While, albumin concentration and albumin to globulin ratio were significantly (P<0.05) decreased, however, globulin concentration in plasma of calves supplemented with OSe and NSe was significantly (P<0.05) higher than that of control group, Organic and nano selenium supplementation significantly decreased (P<0.05) the activity of AST and ALT enzymes and creatinine concentration in plasma compared to that of the control group. The concentrations of IgA and IgG in plasma were increased significantly (P<0.05) with OSe and NSe supplementation compared to the control group, The IgM concentration was comparable among all groups. The percentages of various disease incidence decreased significantly (P<0.05) in OSe and NSe supplemented groups than those of the control group, Morality rate was higher in the control group than that of OSe group, however no mortality was observed in calves of NSe group. Dry matter intake values were the same for different groups, whereas, values of TDN and DCP intake tended to increase with OSe and NSe supplemented diet than those of the control group. Birth weight was comparable among all groups. While, weaning weight, total weight gain and average daily weight gain were significantly (P<0.05) higher for OSe and NSe groups than to the control. Supplementation with OSe and NSe improved feed conversion ratio, which significant decreased (P<0.05), where the amounts of DM, TDN and DCP per one kg weigh gain were less than those of control group. Daily feed cost was comparable among all groups, where feed cost per kg gain was significantly (P<0.05) lower for OSe and NSe groups than control group. The cost price of daily weight gain and net revenue as well as economic efficiency were significantly (P<0.05) higher for OSe and NSe groups compared to those of control group.

Pharmacokinetics in plasma and alveolar regions of healthy calves subcutaneously administered a single dose of enrofloxacin.

This study aimed to analyze the pharmacokinetics of enrofloxacin (ERFX) and its metabolite ciprofloxacin (CPFX) in plasma, as well as their migration to, and retention in, the epithelial lining fluid (ELF) and alveolar cells within the bronchoalveolar fluid (BALF). Four healthy calves were subcutaneously administered a single dose of ERFX (5 mg/kg). ERFX and CPFX dynamics post-administration were analyzed via a non-compartment model, including the absorption phase. The Cmax of plasma ERFX was 1.6 ± 0.4 µg/ml at 2.3 ± 0.5 hr post-administration and gradually decreased to 0.14 ± 0.03 µg/ml at 24 hr following administration. The mean residence time between 0 and 24 hr (MRT0–24) in plasma was 6.9 ± 1.0 hr. ERFX concentrations in ELF and alveolar cells peaked at 3.0 ± 2.0 hr and 4.0 ± 2.3 hr following administration, respectively, and gradually decreased to 0.9 ± 0.8 µg/ml and 0.8 ± 0.5 µg/ml thereafter. The plasma half-life (t1/2) of ERFX was 6.5 ± 0.7 hr, while that in ELF and alveolar cells was 6.5 ± 3.6 and 7.4 ± 4.3 hr, respectively. The Cmax and the area under the concentration-time curve for 0–24 hr for ERFX were significantly higher in alveolar cells than in plasma (P<0.05). These results suggest that ERFX is distributed at high concentrations in ELF and is retained at high concentrations in alveolar cells after 24 hr in the BALF region; hence, ERFX may be an effective therapeutic agent against pneumonia.

Technical note: Rapid field test for the quantification of vitamin E, β-carotene, and vitamin A in whole blood and plasma of dairy cattle

Fast and easy tests for quantifying fat-soluble vitamins such as vitamin E and vitamin A, as well as β-carotene, in whole blood without a need to preprocess blood samples could facilitate assessment of the vitamin status of dairy cattle. The objective of this study was to validate a field-portable fluorometer/spectrophotometer assay for the rapid quantification of these vitamins in whole blood and plasma of dairy cows and calves. We measured the concentrations of vitamin E and β-carotene in whole blood and plasma from 28 dairy cows and 11 calves using the iCheck test (BioAnalyt GmbH, Teltow, Germany) and compared the results with the current analytical standard (HPLC) in 2 independent laboratories, one at the University of Potsdam (Germany) and at one at DSM Nutritional Products Ltd. (Kaiseraugst, Switzerland). For vitamin A, the HPLC measurements were done only in the laboratory in Germany. The whole-blood concentrations of vitamin E as determined by iCheck (blood-hematocrit-corrected) ranged from 1.82 to 4.99 mg/L in dairy cows and 0.34 to 3.40 mg/L in calves. These findings were moderately correlated (R2 = 0.66) with the values assessed by HPLC in dairy cattle (cows + calves). When calves were excluded, the correlation was higher (R2 = 0.961). The β-carotene and vitamin A values obtained by the reference method HPLC were highly correlated with the iCheck methods in whole blood (R2 = 0.99 and 0.88, respectively). In plasma, we observed strong correlations between the concentrations assessed by iCheck and those of HPLC for vitamin E (R2 = 0.97), β-carotene (R2 = 0.98), and vitamin A (R2 = 0.92) in dairy cattle (cows + calves). For vitamin E, β-carotene, and vitamin A, we compared the relationship between the differences obtained by the iCheck assay and the HPLC measurements, as well as the magnitude of measurements, using Bland-Altman plots to test for systematic bias. For all 3 vitamins, the differences values were not outside the 95% acceptability limits; we found no systematic error between the 2 methods for all 3 analytes.

Placental and breastmilk transfer of voriconazole to offspring from pregnant and lactating bottlenose dolphins (Tursiops truncatus).

Fungal pneumonia is a common disease in bottlenose dolphins (Tursiops truncatus), including pregnant and lactating ones. Voriconazole (VRCZ) is commonly used to treat respiratory fungal infections in this species; however, it is unknown whether VRCZ is transferred via the placenta and breastmilk and whether its usage is safe in pregnant and lactating dolphins. We measured VRCZ concentrations in breastmilk and dams', umbilical cord, and calves' plasma samples from four dam-calf dolphin pairs in the Port of Nagoya Public Aquarium, Japan, treated with or without VRCZ. Three pregnant and/or lactating dams were administered VRCZ (loading dose 1.5-2.3mg/kg, for 3 days; maintenance dose 1.5-3.1mg/kg, every 5-18 days), twice daily, orally, without side effects in dams or calves. VRCZ was detected in two dams' umbilical cord plasma (0.14 and 2.35μg/ml) and in one calf's plasma (0.18μg/ml), collected immediately after birth. Further, VRCZ was detected in breastmilk samples (maximum 13.45μg/ml) from three VRCZ-administered dams and in plasma from three calves (maximum 7.54μg/ml) given or nursed from VRCZ-administered dams' breastmilk. The calves' plasma VRCZ concentrations varied, depending on the amount of breastmilk and food consumed. VRCZ concentrations were higher in breastmilk samples than in dams' plasma. To our knowledge, this is the first report on placental and breastmilk VRCZ transfer to offspring in bottlenose dolphins. During VRCZ medication in pregnant and lactating bottlenose dolphins, it is crucial to monitor plasma VRCZ concentrations and any side effects in dams as well as in their calves.

Effect of maternal biotin, folic acid, and vitamin B12 supplementation before parturition on colostral and Holstein calf plasma concentrations in those vitamins

The newborn calf relies on placental and colostral transfers of B vitamins to cover its requirements. This study was conducted to evaluate biotin, folate and vitamin B12 concentrations in colostrum of cows receiving those vitamin supplements and in plasma of their calves fed with their colostrum. According to a 2 × 2 factorial arrangement, non-lactating pregnant cows (n = 34) were assigned to 2 levels of biotin supplement (0 or 20 mg/day of dietary biotin) and 2 levels of folic acid and vitamin B12 supplements (0 or 2.6 g/day of dietary folic acid and 10 mg of intramuscular injections of vitamin B12). Treatments were initiated 26 (SD: 8) days before calving until the parturition. Colostrum sample from the first milking was harvested. Offspring (n = 23) were fed 2.4 (SE: 0.3) kg of their dam colostrum within 3 (SD: 2) h of life (P > 0.24); calves born as twin, stillborn or not receiving their dam colostrum were removed. Calves were blood sampled and weighed 25 (SD: 4) h after birth. Supplementary biotin, folic acid, and vitamin B12 successfully increased their respective prepartum dam plasma and colostrum vitamin concentrations (P < 0.001). Colostral biotin, folate, and vitamin B12 concentrations were respectively increased from 26.8 (95% confidence interval (CI): 20.4–35.1) to 253.7 (95% CI: 193.8–332.3), 673 to 1094 (SE: 52), and 28.6 to 57.9 (SE: 3.3) ng/mL by their respective vitamin supplementation. Colostral IgG concentration did not differ among treatments (P > 0.14) and averaged 49.8 (SD: 23.5) g/L. Calves born to dams receiving folic acid and vitamin B12 supplements were heavier (50 vs. 44, SE: 1 kg; P = 0.003); biotin supplement did not affect calf weight (P = 0.66). Plasma biotin concentrations of calves were increased from 1.1 (95% CI: 0.9–1.4) to 7.5 (95% CI: 6.1–9.2) ng/mL by the maternal biotin supplementation (P < 0.001). Maternal folate and vitamin B12 supplementation during the prepartum period increased calf plasma concentration of folates from 15.9 (SE: 1.9) to 30.8 (SE: 1.8) ng/mL and tended to augment plasma vitamin B12 concentration of offspring, from 0.76 (95% CI: 0.51–1.12) to 1.25 (95% CI: 0.87–1.80) ng/mL (P < 0.07). No treatment effect was noted on calf plasma concentration of IgG (P > 0.54). Results suggest that biotin, folic acid and vitamin B12 supplementation given to the dam before calving increased supply of those vitamins for newborn calves who rely on external supply of the B vitamins to fulfill their requirements before the development of their functional rumen.

70 Effects of copper, zinc, and manganese intake in late gestation on milk, cow plasma, and calf plasma trace mineral concentrations post-calving in beef cattle

Abstract Multiparous, fall-calving beef cows [n = 48; 649 ± 80 (SD) kg BW; 5.3 ± 0.5 BCS] were individually-fed tall fescue-based hay (12.2% CP, 61.5% NDF) and supplemented to meet/exceed nutrient recommendations except Cu, Zn, and Mn. From approximately 90 d pre-calving to 11 d post-calving, cows received: no additional Cu, Zn, or Mn (CON); Cu, Zn, and Mn sulfates (ITM) or metal methionine hydroxy analogue chelates (CTM, MINTREX®, Novus International) supplying 133% NASEM recommendations; or Cu, Zn, and Mn sulfates and chelates supplying 100% recommendations (reduce and replace, RR). Treatment, sampling day, their interaction, and breeding group were fixed effects with cow as the experimental unit. Colostrum and milk Cu and Mn and plasma Mn were generally not detectable. Colostrum Zn was greater (P ≤ 0.03) in CTM and ITM than CON and RR. All treatments had greater (P &lt; 0.001) colostrum Zn than d 35 milk, which was greater (P ≤ 0.03) than d 60. Treatment did not affect (P ≥ 0.19) cow or calf plasma Cu or Zn post-calving. Calf plasma Zn decreased (P ≤ 0.02) from 0 to 35 d of age. Calf plasma Cu increased (P &lt; 0.01) from 0 to 35 d, then decreased (P = 0.01) from 35 to 60 d. Cow plasma Zn and Cu were greater (P ≤ 0.02) at lactation d 35 and 60 than 1 h post-calving. Pearson correlation coefficients were used to determine relationships among cow and calf mineral status. There were weak positive correlations (P ≤ 0.06) between calf plasma and milk Zn at d 35 and 60. Cow and calf plasma Zn immediately post-calving had a weak negative correlation (P = 0.04). These results indicate greater Zn concentration in beef cow colostrum than milk, and suggest calf circulating Zn is partially dependent on milk Zn concentration.

Metabolomic studies as a tool for determining the post-mortem interval (PMI) in stillborn calves

BackgroundPerinatal mortality may vary between herds, but the cost of deaths are always higher than value of the calf. When diagnosing the cause of a calf’s death it is important to determine when it occurred, before or after calving. Metabolomics is widely used to identify many human diseases, but quite rarely applied in veterinary science. The aim of this study was to compare the metabolic profiles of calves with different times of death and those of calves born alive. Into the study, twenty one healthy controls (singleton, normal assisted calving, born alive) and 75 stillborn (SB) calves (with a gestation length of ≥260 days, SB, or dead within 6 h of birth) were enrolled. Plasma and urine from SB and control calves were investigated by proton nuclear magnetic resonance based metabolomic methods. SB calves were divided into four PMI groups. One PMI group included calves that died after calving and the other groups - three comprised in utero deaths, based on pathophysiological changes (lung inflation, autolysis in internal organs, hemoglobin imbibition in the pleura and aortic arch). Partial Least Squares - Discriminant Analysis models based on plasma metabolites were calculated, reflecting assumed data clustering.ResultsTwenty six metabolites in plasma and 29 in urine changed significantly with PMI according to one way analysis of variance. Half the metabolites in plasma and the majority in urine increased with PMI. Six metabolites increased simultaneously in plasma and urine: acetate, sn-glycero-3-phosphocholine (GPC), leucine, valine, creatine, and alanine.ConclusionsPost-mortem changes in calves were associated with molecular variations in blood plasma and urine, showing the greatest differences for the group in which the post-mortem pathological changes were the most advanced. The results of the study show that evaluation of calf plasma or urine may be used as a diagnostic method for the determination of the PMI. Moreover, the metabolites, which unambiguously increased or decreased, can be used as potential biomarkers of PMI.

Effects of pH and the plasma or serum concentrations of total calcium, chloride, magnesium, l-lactate, and albumin on the plasma ionized calcium concentration in calves.

BackgroundThe plasma ionized calcium concentration (cCa2+) represents the biologically active form of calcium and is the preferred method for evaluating calcium status in animals. Different pH‐corrective equations have been developed for human plasma, but the validity of the equations for bovine plasma is unknown.HypothesisWe hypothesized that pH‐corrective equations for bovine plasma would be similar to those used for human plasma; cCa2+ was dependent on the plasma concentrations of total calcium (cTCa), chloride (cCl), L‐lactate (cLactate), and albumin (cAlbumin); and the in vitro and in vivo cCa2+‐pH relationships would differ.AnimalsTen healthy calves (in vitro study), 1426 critically ill calves.MethodsThe in vitro plasma log10(cCa2+)‐pH relationship was determined by CO2 tonometry of 465 plasma samples. Plasma cCl was altered by equivolume dilution of plasma with 3 electrolyte solutions of different cCl. The in vivo plasma cCa2+‐pH relationship was investigated and validated using clinicopathologic data extracted from the medical records of 950 (model development) and 476 (model validation) critically ill calves.ResultspH‐corrective equations for bovine plasma were similar to those used for human plasma. Plasma cCa2+ increased in vitro with increases in plasma cCl. Plasma cCa2+ in critically ill calves was associated with plasma cTCa, blood pH, plasma cCl, serum cMg, and cL‐lactate (R 2 = 0.69) but not plasma cAlbumin.Conclusions and Clinical ImportanceCalculation of cCa2+ from cTCa in calf plasma or serum requires adjustment for at least pH and cCl when 1 or both are outside the reference range.

Effect of feeding rice whole crop silage on growth rate, levels of vitamin A, β-carotene, vitamin E and IGF-1 in plasma and skeletal muscle protein degradation in Japanese black calves.

This study evaluated the effects of rice whole crop silage (RWCS) on growth, plasma levels of vitamin A, β-carotene, vitamin E and IGF-1, and expression of genes involved in muscle protein degradation and synthesis in Japanese Black calves. Eleven calves were divided into RWCS (fed RWCS ad libitum and concentrate, n=5) and control groups (fed hay ad libitum and concentrate, n=6). Final body weight and dairy gain were significantly larger in the RWCS group compared with the control group. Plasma β-carotene and vitamin E concentrations were significantly higher in the RWCS group compared with control group. Although plasma vitamin E concentration in the RWCS group significantly increased from 4 to 9months of age, it did not increase in the control group. At 6months of age in the RWCS group, ubiquitin B (p<0.05) and calpain 1 (p=0.097) mRNA expression were lower than control group, but they were not different between groups at 9months of age. These results indicate that RWCS increases plasma β-carotene level and promotes muscle growth because of a decrease in the rate of protein degradation, but the effect is lost with the increase in plasma vitamin E level.

Detection of endotoxin in plasma of hospitalized diarrheic calves.

To investigate whether lipopolysaccharide (LPS) is present in plasma of calves with naturally occurring diarrhea. The second objective was to determine whether plasma [LPS] correlates with clinical, hematological, biochemical, and acid-base variables, and whether [LPS] differs between surviving and nonsurviving diarrheic calves. Prospective observational study (January 2012-May 2014). Veterinary teaching hospital. Thirty-four calves <28 days old admitted for diagnosis and treatment of diarrhea and 30 healthy control calves. Admission demographics, physical examination, blood gas, biochemistry analysis, and outcome data were recorded. Plasma concentration of LPS was determined using a bovine LPS ELISA assay. Plasma [LPS] was detected in both healthy and diarrheic calves. Plasma [LPS] was significantly higher in diarrheic than healthy calves (median: 0.99ng/mL; Interquartile range (IQR): 0.068, vs 0.88ng/mL; 0.065ng/mL, respectively; P < 0.001). Plasma [LPS] was higher in nonsurviving (1.04ng/mL; 0.07ng/mL) than in surviving calves (0.98ng/mL; 0.022ng/mL; P < 0.001). Plasma [LPS] was higher in beef (1.07ng/mL; 0.182ng/mL) than in dairy diarrheic calves (0.99ng/mL; 0.022ng/mL; P < 0.001). In diarrheic calves, plasma [LPS] correlated with [l-lactate] (r2 = 0.496; P = 0.002); hypoglycemia (r2 = -0.453; P = 0.007); increased unmeasured strong ions (r2 = 0.332; P = 0.050), [Mg2+ ] (r2 = 0.475; P = 0.004), and [phosphate] (r2 = 0.468; P = 0.005), and increased aspartate aminotransferase activity (r2 = 0.348; P = 0.003). This study highlights a potential role of LPS in the pathogenesis of metabolic derangements such as hyperlactatemia, hypoglycemia, and increased concentration of unmeasured strong anions in diarrheic calves. Further investigation evaluating the effect of LPS on l-lactate and glucose metabolism in diarrheic calves is warranted.